Inhibition of sucrose- and starch-induce
β
B. Lembcke; U. R. FΓΆlsch; W. Gatzemeier; B. LΓΌcke; R. Ebert; E. Siegel; W. Creut
π
Article
π
1991
π
Springer
π
English
β 706 KB
The absorbable deoxynojirimycin derivative emiglitate (BAY o 1248) is a potent competitive inhibitor of small intestinal alpha-glucosidases in man. In two similar randomized, placebo-controlled, double blind investigations, the efficacy, duration of action and tolerability of single doses of 10, 20